BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9718428)

  • 1. Serum tests for diagnosis and follow-up of hepatocellular carcinoma after treatment.
    Trojan J; Raedle J; Zeuzem S
    Digestion; 1998 Jul; 59 Suppl 2():72-4. PubMed ID: 9718428
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison between alpha-fetoprotein and p53 antibodies in the diagnosis of hepatocellular carcinoma.
    Edis C; Kähler C; Klotz W; Herold M; Feichtinger H; Königsreiner A; Margreiter R; Jaschke W; Vogel W
    Transplant Proc; 1998 May; 30(3):780-1. PubMed ID: 9595095
    [No Abstract]   [Full Text] [Related]  

  • 3. Des-gamma-carboxyprothrombin in hepatocellular carcinoma after vitamin K1 injection.
    Buffet C; Bismuth E; Hagege H; Etienne JP
    Dig Dis Sci; 1989 Jun; 34(6):963-4. PubMed ID: 2470560
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatocellular carcinoma, a unique tumor with a lack of biomarkers.
    Debes JD; Carrera E; Mattos AZ; Prieto JE; Boonstra A;
    Ann Hepatol; 2019; 18(6):786-787. PubMed ID: 31494068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal prothrombin (DES-gamma-carboxy prothrombin) in hepatocellular carcinoma.
    Nakao A; Virji A; Iwaki Y; Carr B; Iwatsuki S; Starzl E
    Hepatogastroenterology; 1991 Oct; 38(5):450-3. PubMed ID: 1722483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-fetoprotein in hepatocellular carcinoma surveillance: wake not the dead.
    Giannini EG; Farinati F; Trevisani F
    Hepatology; 2011 Jul; 54(1):376-7. PubMed ID: 21710475
    [No Abstract]   [Full Text] [Related]  

  • 7. Elevated alpha-fetoprotein: differential diagnosis - hepatocellular carcinoma and other disorders.
    Wong RJ; Ahmed A; Gish RG
    Clin Liver Dis; 2015 May; 19(2):309-23. PubMed ID: 25921665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-fetoprotein in early hepatocellular carcinoma.
    Marrero JA; Feng Z
    Gastroenterology; 2010 Jan; 138(1):400-1. PubMed ID: 19932214
    [No Abstract]   [Full Text] [Related]  

  • 9. [Molecular markers for early diagnosis of hepatocellular carcinoma].
    Yao DF
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):492. PubMed ID: 15329213
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies of vitamin K sensitivity of PIVKA-II in patients with hepatocellular carcinoma].
    Furukawa M; Nakanishi T; Okuda H; Obata H
    Nihon Shokakibyo Gakkai Zasshi; 1988 Dec; 85(12):2583-9. PubMed ID: 2854170
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of prothrombin induced by vitamin K absence, macrophage migration inhibitory factor and Golgi protein-73 versus alpha fetoprotein for hepatocellular carcinoma diagnosis and surveillance.
    Ismail MM; Morsi HK; Abdulateef NA; Noaman MK; Abou El-Ella GA
    Scand J Clin Lab Invest; 2017 May; 77(3):175-183. PubMed ID: 28276727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. History and recent progress in evaluation of the fucosylated alpha-fetoprotein fraction.
    Aoyagi Y; Tamura Y; Suda T
    J Gastroenterol Hepatol; 2011 Apr; 26(4):615-6. PubMed ID: 21418297
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study.
    Ji J; Wang H; Li Y; Zheng L; Yin Y; Zou Z; Zhou F; Zhou W; Shen F; Gao C
    PLoS One; 2016; 11(4):e0153227. PubMed ID: 27070780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients.
    Lim TS; Kim DY; Han KH; Kim HS; Shin SH; Jung KS; Kim BK; Kim SU; Park JY; Ahn SH
    Scand J Gastroenterol; 2016 Mar; 51(3):344-53. PubMed ID: 26340708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening and detection of hepatocellular carcinoma.
    Simpson HN; McGuire BM
    Clin Liver Dis; 2015 May; 19(2):295-307. PubMed ID: 25921664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma].
    Yamashiki M; Kosaka Y
    Rinsho Byori; 1989 Feb; 37(2):118-21. PubMed ID: 2471846
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnostic performance of tumor markers AFP and PIVKA-II in Chinese hepatocellular carcinoma patients.
    Huang S; Jiang F; Wang Y; Yu Y; Ren S; Wang X; Yin P; Lou J
    Tumour Biol; 2017 Jun; 39(6):1010428317705763. PubMed ID: 28621228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of primary hepatocellular carcinoma.
    Tong MJ
    Gastroenterology; 1986 Nov; 91(5):1306-7. PubMed ID: 2428693
    [No Abstract]   [Full Text] [Related]  

  • 19. [Symptoms of hepatocellular carcinoma. Laboratory tests used for its diagnosis and screening].
    Gervain J
    Orv Hetil; 2010 Aug; 151(35):1415-7. PubMed ID: 20719715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous drastic reduction of alpha-fetoprotein in hepatocellular carcinoma.
    Phadke AY; Desai HG
    Indian J Gastroenterol; 1996 Jul; 15(3):111. PubMed ID: 8840646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.